J&J beat and raised: Q3 adj EPS $2.59, revenue $25.4B up 5.9% YoY, FY26 EPS guide lifted to $11.05-$11.15. Innovative Medicine grew 7.9% operationally even with a 690bp STELARA headwind, so the base b
JNJ
$285.75
+0.79%
What changed
Watch: $JNJ
Why it matters
Watch: $JNJ — impact context not separately stored; see What changed.